Colgate-Palmolive Company (CL) reported $21.28B of revenue for the twelve months ended Sep 30, 2026. That is up 5.9% from the year before. Revenue for fiscal 2025 was $20.38B.

Yes. Colgate-Palmolive Company earned $2.05B in net income for the twelve months ended Sep 30, 2026, a net margin of 9.6%.

How much cash and debt does CL have?

Colgate-Palmolive Company reported $1.53B in cash and cash equivalents and $7.18B of debt on its most recent balance sheet in SEC filings.

How fast is CL revenue growing?

Colgate-Palmolive Company's revenue changed +1.4% in fiscal 2025, to $20.38B. Its compound annual growth rate was +4.4% over 5 years and +2.4% over 10 years.

What is CL gross margin?

Colgate-Palmolive Company's gross profit was $12.90B on $21.28B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 60.6%.

What is CL free cash flow?

Colgate-Palmolive Company generated $3.79B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $4.37B less capital expenditures.

What is CL earnings per share?

Diluted earnings per share were $2.56 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CL last report financial results?

The latest statements here come from Colgate-Palmolive Company's 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.

Financials · CL

Colgate-Palmolive Company (CL) financials

For the twelve months ended Sep 30, 2026, Colgate-Palmolive Company reported $21.28B of revenue and $2.05B of net income.

Revenue, TTM: $21.28B
Revenue growth, YoY: +5.9%
Net income, TTM: $2.05B
Net income growth, YoY: -29.4%
Net margin: 9.6%
Free cash flow, TTM: $3.79B
EPS, diluted, TTM: $2.56
EPS growth, YoY: -28.1%
Cash: $1.53B
Total debt: $7.18B
P/E: 38.21
P/S: 3.69
Market cap: $78.45B

Annual revenue$20.38B

FY2016FY2025

Annual net income$2.13B

FY2016FY2025

Annual free cash flow$3.63B

FY2016FY2025

CL revenue and earnings growth

CL revenueQ3 2026$5.37B

Quarter YoY: +4.6%
QoQ: +0.1%
FY YoY: +1.4%
5Y CAGR: +4.4%
10Y CAGR: +2.4%

CL revenue was $5.37B in fiscal Q3 2026 (ended Sep 30, 2026), up 4.6% from a year earlier and up 0.1% from the prior quarter. For the full fiscal 2025 it was $20.38B, up 1.4% from fiscal 2024. Compound annual growth was +4.4% over 5 years and +2.4% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

CL net incomeQ3 2026$751.00M

Quarter YoY: +2.2%
QoQ: +8.4%
FY YoY: -26.2%
5Y CAGR: -4.6%
10Y CAGR: +4.4%

CL net income was $751.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 2.2% from a year earlier and up 8.4% from the prior quarter. For the full fiscal 2025 it was $2.13B, down 26.2% from fiscal 2024. Compound annual growth was -4.6% over 5 years and +4.4% over 10 years. It rose in 5 of the last 10 fiscal years.

CL EPSQ3 2026$0.94

Quarter YoY: +3.3%
QoQ: +9.3%
FY YoY: -25.1%
5Y CAGR: -3.5%
10Y CAGR: +5.6%

CL diluted EPS was $0.94 in fiscal Q3 2026 (ended Sep 30, 2026), up 3.3% from a year earlier and up 9.3% from the prior quarter. For the full fiscal 2025 it was $2.63, down 25.1% from fiscal 2024. Compound annual growth was -3.5% over 5 years and +5.6% over 10 years.

CL free cash flowQ3 2026$1.04B

Quarter YoY: -6.2%
QoQ: +19.6%
FY YoY: +2.5%
5Y CAGR: +1.9%
10Y CAGR: +4.9%

CL free cash flow was $1.04B in fiscal Q3 2026 (ended Sep 30, 2026), down 6.2% from a year earlier and up 19.6% from the prior quarter. For the full fiscal 2025 it was $3.63B, up 2.5% from fiscal 2024. Compound annual growth was +1.9% over 5 years and +4.9% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$20.38B	$20.10B	$19.46B	$17.97B	$17.42B	$16.47B	$15.69B	$15.54B	$15.45B	$15.20B
Cost of revenue	$8.13B	$7.94B	$8.13B	$7.72B	$7.05B	$6.45B	$6.37B	$6.31B	$6.17B	$6.07B
Gross profit	$12.25B	$12.16B	$11.33B	$10.25B	$10.38B	$10.02B	$9.32B	$9.23B	$9.28B	$9.12B
Research and development	$366.00M	$355.00M	$343.00M	$320.00M	$307.00M	$290.00M	$281.00M	$277.00M	$285.00M	$289.00M
Selling, general and admin	$7.90B	$7.73B	$7.15B	$6.57B	$6.41B	$6.02B	$5.58B	$5.39B	$5.40B	$5.14B
Operating income	$3.31B	$4.27B	$3.98B	$2.89B	$3.33B	$3.88B	$3.55B	$3.69B	$3.71B	$3.96B
Interest expense	$267.00M	$292.00M	$287.00M	$167.00M	-	-	-	-	-	-
Pre-tax income	$3.06B	$3.96B	$3.39B	$2.66B	$3.09B	$3.65B	$3.30B	$3.46B	$3.49B	$3.74B
Income tax	$798.00M	$907.00M	$937.00M	$693.00M	$749.00M	$787.00M	$774.00M	$906.00M	$1.31B	$1.15B
Net income	$2.13B	$2.89B	$2.30B	$1.78B	$2.17B	$2.69B	$2.37B	$2.40B	$2.02B	$2.44B
EPS, basic	$2.64	$3.53	$2.78	$2.13	$2.56	$3.15	$2.76	$2.76	$2.30	$2.74
EPS, diluted	$2.63	$3.51	$2.77	$2.13	$2.55	$3.14	$2.75	$2.75	$2.28	$2.72
Diluted shares	811.1M	823.2M	829.2M	838.8M	848.3M	859.3M	861.1M	873.0M	887.8M	898.4M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$1.29B	$1.10B	$966.00M	$775.00M	$832.00M	$888.00M	$883.00M	$726.00M	$1.53B	$1.31B
Short-term investments	$107.00M	$160.00M	$179.00M	-	-	-	-	-	-	-
Receivables	$1.68B	$1.52B	$1.59B	$1.50B	$1.30B	$1.26B	$1.44B	$1.40B	$1.48B	$1.41B
Inventory	$2.03B	$1.99B	$1.93B	$2.07B	$1.69B	$1.67B	$1.40B	$1.25B	$1.22B	$1.17B
Current assets	$5.71B	$5.32B	$5.28B	$5.11B	$4.40B	$4.34B	$4.18B	$3.79B	$4.64B	$4.34B
Goodwill	$3.12B	$3.27B	$3.41B	$3.35B	$3.28B	$3.82B	$3.51B	$2.53B	$2.22B	$2.11B
Total assets	$16.33B	$16.05B	$16.39B	$15.73B	$15.04B	$15.92B	$15.03B	$12.16B	$12.68B	$12.12B
Current liabilities	$6.85B	$5.76B	$4.74B	$4.00B	$4.05B	$4.40B	$4.04B	$3.34B	$3.41B	$3.31B
Short-term debt	$1.11B	$652.00M	$20.00M	$14.00M	$12.00M	$9.00M	$254.00M	$0	$0	$0
Long-term debt	$6.87B	$7.29B	$8.22B	$8.74B	$7.19B	$7.33B	$7.33B	$6.35B	$6.57B	$6.52B
Total debt	$7.99B	$7.94B	$8.24B	$8.76B	$7.21B	$7.34B	$7.59B	$6.35B	$6.57B	$6.52B
Total liabilities	$15.96B	$15.50B	$15.44B	$14.93B	$14.07B	$14.82B	$14.48B	$11.96B	$12.43B	$12.11B
Shareholders' equity	$54.00M	$212.00M	$609.00M	$401.00M	$609.00M	$743.00M	$117.00M	-$102.00M	-$60.00M	-$243.00M

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$4.20B	$4.11B	$3.75B	$2.56B	$3.33B	$3.72B	$3.13B	$3.06B	$3.05B	$3.14B
Capital expenditures	$564.00M	$561.00M	$705.00M	$696.00M	$567.00M	$409.00M	$335.00M	$436.00M	$553.00M	$593.00M
Free cash flow	$3.63B	$3.55B	$3.04B	$1.86B	$2.76B	$3.31B	$2.80B	$2.62B	$2.50B	$2.55B
Investing cash flow	-$817.00M	-$534.00M	-$742.00M	-$1.60B	-$592.00M	-$779.00M	-$2.10B	-$1.17B	-$471.00M	-$499.00M
Financing cash flow	-$3.26B	-$3.39B	-$2.79B	-$952.00M	-$2.77B	-$2.92B	-$870.00M	-$2.68B	-$2.45B	-$2.23B
Share repurchases	$1.21B	$1.74B	$1.13B	$1.31B	$1.32B	$1.48B	$1.20B	$1.24B	$1.40B	$1.33B
Stock-based compensation	$155.00M	$135.00M	$122.00M	$125.00M	$135.00M	$107.00M	$100.00M	$109.00M	$127.00M	$123.00M
Depreciation and amortization	$630.00M	$605.00M	$567.00M	$545.00M	$556.00M	$539.00M	$519.00M	$511.00M	$475.00M	$443.00M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	1.4%	3.3%	8.3%	3.1%	5.8%	5.0%	1.0%	0.6%	1.7%	-5.2%
Net income growth, YoY	-26.2%	25.6%	28.9%	-17.6%	-19.6%	13.9%	-1.4%	18.6%	-17.1%	76.4%
EPS growth, YoY	-25.1%	26.7%	30.0%	-16.5%	-18.8%	14.2%	0.0%	20.6%	-16.2%	78.9%
Gross margin	60.1%	60.5%	58.2%	57.0%	59.6%	60.8%	59.4%	59.4%	60.0%	60.0%
Operating margin	16.2%	21.2%	20.5%	16.1%	19.1%	23.6%	22.6%	23.8%	24.0%	26.0%
Net margin	10.5%	14.4%	11.8%	9.9%	12.4%	16.4%	15.1%	15.4%	13.1%	16.1%
Free cash flow margin	17.8%	17.6%	15.6%	10.4%	15.8%	20.1%	17.8%	16.9%	16.2%	16.8%
Return on equity	3948.1%	1362.7%	377.7%	445.1%	355.7%	362.7%	2023.1%	-	-	-
Return on assets	13.1%	18.0%	14.0%	11.3%	14.4%	16.9%	15.7%	19.7%	16.0%	20.1%
Current ratio	0.83	0.92	1.11	1.28	1.09	0.99	1.03	1.14	1.36	1.31
Debt to equity	147.89	37.46	13.53	21.83	11.83	9.88	64.85	-	-	-

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$5.37B	$5.36B	$5.32B	$5.23B	$5.13B	$5.11B	$4.91B	$4.95B	$5.03B	$5.06B	$5.07B	$4.95B
Cost of revenue	$2.14B	$2.06B	$2.10B	$2.08B	$2.08B	$2.04B	$1.92B	$1.96B	$1.96B	$1.99B	$2.03B	$2.00B
Gross profit	$3.23B	$3.30B	$3.23B	$3.15B	$3.05B	$3.07B	$2.99B	$2.98B	$3.07B	$3.07B	$3.04B	$2.95B
Selling, general and admin	$2.11B	$2.13B	$2.08B	$2.07B	$1.97B	$1.96B	$1.90B	$1.90B	$1.98B	$1.94B	$1.92B	$1.80B
Operating income	$1.09B	$1.02B	$964.00M	$92.00M	$1.06B	$1.08B	$1.08B	$1.06B	$1.06B	$1.09B	$1.05B	$1.07B
Interest expense	$62.00M	$62.00M	$62.00M	$64.00M	$67.00M	$71.00M	$66.00M	$66.00M	$74.00M	$78.00M	$73.00M	-
Pre-tax income	$1.02B	$950.00M	$892.00M	$108.00M	$992.00M	$1.01B	$953.00M	$993.00M	$986.00M	$1.01B	$967.00M	$988.00M
Income tax	$240.00M	$231.00M	$211.00M	$113.00M	$226.00M	$234.00M	$227.00M	$214.00M	$210.00M	$243.00M	$238.00M	$228.00M
Net income	$751.00M	$693.00M	$646.00M	-$37.00M	$735.00M	$743.00M	$690.00M	$739.00M	$737.00M	$731.00M	$683.00M	$718.00M
EPS, basic	$0.94	$0.87	$0.81	-$0.04	$0.91	$0.92	$0.85	$0.91	$0.90	$0.89	$0.83	$0.86
EPS, diluted	$0.94	$0.86	$0.80	-$0.04	$0.91	$0.91	$0.85	$0.89	$0.90	$0.89	$0.83	$0.86
Diluted shares	799.7M	801.8M	805.1M	-	810.2M	813.3M	815.0M	-	822.5M	823.7M	825.9M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$1.53B	$1.37B	$1.33B	$1.29B	$1.28B	$1.22B	$1.11B	$1.10B	$1.23B	$1.11B	$1.08B	$966.00M
Short-term investments	-	-	-	$107.00M	-	-	-	$160.00M	-	-	-	$179.00M
Receivables	$1.90B	$1.96B	$1.89B	$1.68B	$1.81B	$1.77B	$1.73B	$1.52B	$1.71B	$1.82B	$1.81B	$1.59B
Inventory	$2.18B	$2.18B	$2.09B	$2.03B	$2.11B	$2.12B	$2.13B	$1.99B	$2.04B	$1.92B	$1.91B	$1.93B
Current assets	$6.36B	$6.31B	$6.08B	$5.71B	$6.04B	$6.00B	$5.81B	$5.32B	$5.81B	$5.65B	$5.64B	$5.28B
Goodwill	$3.08B	$3.10B	$3.11B	$3.12B	$3.70B	$3.70B	$3.33B	$3.27B	$3.39B	$3.32B	$3.34B	$3.41B
Total assets	$16.74B	$16.79B	$16.61B	$16.33B	$17.51B	$17.47B	$16.65B	$16.05B	$16.77B	$16.48B	$16.57B	$16.39B
Current liabilities	$6.64B	$6.15B	$5.93B	$6.85B	$6.50B	$6.78B	$6.86B	$5.76B	$5.57B	$5.35B	$5.31B	$4.74B
Short-term debt	-	-	-	$1.11B	-	-	$1.70B	$652.00M	$20.00M	$21.00M	$20.00M	$20.00M
Long-term debt	$7.18B	$7.82B	$7.94B	$6.87B	$7.31B	$7.14B	$6.57B	$7.29B	$7.91B	$8.15B	$8.15B	$8.22B
Total debt	$7.18B	$7.82B	$7.94B	$7.99B	$7.31B	$7.14B	$8.27B	$7.94B	$7.93B	$8.17B	$8.17B	$8.24B
Total liabilities	$16.10B	$16.22B	$16.12B	$15.96B	$16.27B	$16.42B	$15.91B	$15.50B	$15.94B	$16.00B	$15.95B	$15.44B
Shareholders' equity	$288.00M	$236.00M	$145.00M	$54.00M	$856.00M	$702.00M	$363.00M	$212.00M	$435.00M	$123.00M	$230.00M	$609.00M

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$1.17B	$995.00M	$747.00M	$1.45B	$1.26B	$884.00M	$600.00M	$1.27B	$1.17B	$990.00M	$681.00M	$1.14B
Capital expenditures	$134.00M	$128.00M	$138.00M	$177.00M	$155.00M	$108.00M	$124.00M	$184.00M	$134.00M	$117.00M	$126.00M	$197.00M
Free cash flow	$1.04B	$867.00M	$609.00M	$1.28B	$1.11B	$776.00M	$476.00M	$1.08B	$1.03B	$873.00M	$555.00M	$939.00M
Investing cash flow	-$137.00M	-$122.00M	-$122.00M	-$103.00M	-$154.00M	-$401.00M	-$159.00M	-$80.00M	-$150.00M	-$111.00M	-$193.00M	-$143.00M
Financing cash flow	-$858.00M	-$851.00M	-$563.00M	-$1.36B	-$1.03B	-$409.00M	-$458.00M	-$1.28B	-$904.00M	-$845.00M	-$361.00M	-$992.00M
Share repurchases	$330.00M	$291.00M	$306.00M	$406.00M	$288.00M	$232.00M	$284.00M	$455.00M	$295.00M	$480.00M	$509.00M	$245.00M
Stock-based compensation	$63.00M	$38.00M	$40.00M	$28.00M	$72.00M	$32.00M	$23.00M	$27.00M	$65.00M	$24.00M	$19.00M	$25.00M
Depreciation and amortization	$159.00M	$155.00M	$156.00M	$173.00M	$158.00M	$151.00M	$148.00M	$148.00M	$150.00M	$157.00M	$150.00M	$150.00M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	4.6%	4.9%	8.4%	5.8%	1.9%	1.0%	-3.0%	-0.1%	2.4%	4.9%	6.2%	6.9%
Net income growth, YoY	2.2%	-6.7%	-6.4%	-	-0.3%	1.6%	1.0%	2.9%	4.1%	45.6%	83.6%	14260.0%
EPS growth, YoY	3.3%	-5.5%	-5.9%	-	1.1%	2.2%	2.4%	3.5%	4.7%	48.3%	84.4%	-
Gross margin	60.2%	61.5%	60.6%	60.2%	59.4%	60.1%	60.8%	60.3%	61.1%	60.6%	60.0%	59.6%
Operating margin	20.3%	19.0%	18.1%	1.8%	20.6%	21.1%	21.9%	21.5%	21.2%	21.6%	20.7%	21.7%
Net margin	14.0%	12.9%	12.1%	-0.7%	14.3%	14.5%	14.1%	14.9%	14.6%	14.5%	13.5%	14.5%
Free cash flow margin	19.3%	16.2%	11.4%	24.4%	21.6%	15.2%	9.7%	21.9%	20.5%	17.3%	11.0%	19.0%
Current ratio	0.96	1.03	1.02	0.83	0.93	0.89	0.85	0.92	1.04	1.06	1.06	1.11
Debt to equity	24.94	33.15	54.74	147.89	8.54	10.18	22.78	37.46	18.23	66.40	35.53	13.53

Source: XBRL data Colgate-Palmolive Company files with the SEC, latest filing dated Oct 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 2-for-1, first reported Jul 25, 2013.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CL peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CL	$21.28B	+5.9%	$2.05B	9.6%	$78.45B
PGProcter & Gamble Company	$87.92B	+3.5%	$16.03B	18.2%	$387.30B
ULUnilever PLC	€50.50B	-3.8%	€9.47B	18.7%	$145.87B
ECLEcolab Inc.	$17.37B	+9.3%	$2.08B	12.0%	$85.78B
HLNHaleon plc	£11.03B	-1.8%	£1.67B	15.1%	$40.24B
ELEstee Lauder Companies Inc.	$15.28B	+5.8%	$368.00M	2.4%	$39.00B
KVUEKenvue Inc.	$15.53B	+3.5%	$1.69B	10.9%	$37.57B
CHDChurch & Dwight Company Inc.	$6.25B	+1.7%	$774.80M	12.4%	$26.28B
ELFe.l.f. Beauty Inc.	$1.94B	+39.9%	$86.64M	4.5%	$6.48B

CL FAQ

9 questions

What is CL revenue?
Colgate-Palmolive Company (CL) reported $21.28B of revenue for the twelve months ended Sep 30, 2026. That is up 5.9% from the year before. Revenue for fiscal 2025 was $20.38B.
Is CL profitable?
Yes. Colgate-Palmolive Company earned $2.05B in net income for the twelve months ended Sep 30, 2026, a net margin of 9.6%.
How much cash and debt does CL have?
Colgate-Palmolive Company reported $1.53B in cash and cash equivalents and $7.18B of debt on its most recent balance sheet in SEC filings.
How fast is CL revenue growing?
Colgate-Palmolive Company's revenue changed +1.4% in fiscal 2025, to $20.38B. Its compound annual growth rate was +4.4% over 5 years and +2.4% over 10 years.
What is CL gross margin?
Colgate-Palmolive Company's gross profit was $12.90B on $21.28B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 60.6%.
What is CL free cash flow?
Colgate-Palmolive Company generated $3.79B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $4.37B less capital expenditures.
What is CL earnings per share?
Diluted earnings per share were $2.56 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CL last report financial results?
The latest statements here come from Colgate-Palmolive Company's 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.
Where does this CL financial data come from?
Quantisnow builds these statements from the structured XBRL data Colgate-Palmolive Company files with the SEC. It is provided for information only and is not investment advice.